Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05370911 · ClinicalTrials.gov registry record · Phase 1

Effects of Repeated Psilocybin Dosing in OCD

A Phase 1 study of Obsessive - Compulsive Disorder, sponsored by Yale University.

Active
Registry status
Phase 1
Development phase
30
Enrollment target
2
Study locations

NCT05370911 is a Phase 1 study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Yale University. The registered enrollment target is 30 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05370911, a Phase 1 study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

This study aims to investigate the effects of repeated dosing of oral psilocybin on obsessive-compulsive disorder (OCD) symptomatology in a randomized, waitlist-controlled design with blinded independent ratings, and assess psychological mechanisms that may mediate psilocybin's therapeutic effects on OCD.

Conditions Studied

Obsessive - Compulsive Disorder

Interventions

  • DRUG Psilocybin

Study Locations (2)

Connecticut

  • Enact Research Collaborative (40 Temple St, 4th Floor) - New Haven
  • Yale Program for Psychedelic Research - New Haven

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-07-20
Est. Completion 2027-07
Phase Phase 1

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05370911

The ClinicalTrials.gov registry entry for NCT05370911 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin is the first listed.

NCT05370911 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05370911 about?

NCT05370911 is a clinical study titled "Effects of Repeated Psilocybin Dosing in OCD". This study aims to investigate the effects of repeated dosing of oral psilocybin on obsessive-compulsive disorder (OCD) symptomatology in a randomized, waitlist-controlled design with blinded independent ratings, and assess psychological mechanisms that may mediate psilocybin's therapeutic effects o...

What is the current status of trial NCT05370911?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2023-07-20. Estimated completion is 2027-07.

What conditions does trial NCT05370911 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT05370911?

The interventions under investigation include: Psilocybin (DRUG).

Who is sponsoring clinical trial NCT05370911?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05370911 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obsessive - Compulsive Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.